The location of cis-acting regulatory regions within the long terminal repeat (LTR) of the human T-cell leukemia virus type I (HTLV-1) was determined. The sequences present between nucleotides -350 and -55 (cap site +1) contain an enhancer element that is active in lymphoid and nonlymphoid cell lines. The sequences located near the "TATA" and RNA initiation sites contain a promoter, the activity of which can be augmented by homologous and heterologous enhancer elements. A region responsive to transacting transcription factors present in HTLV-I-and HTLV type II-infected cells is located between nucleotides -159 and +315. HTLV-I LTR deletion mutants respond in a similar manner both to the trans-acting factors present in infected cells and to the tat protein encoded by the x-lor region of the genome, thus providing further evidence that the tat protein mediates transcriptional trans-activation of the LTR in HTLV-infected cells.
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The human T-cell leukemia virus type I (HTLV-I) is the etiologic agent of adult T-cell leukemia lymphoma, a disease endemic to certain geographic regions (1) (2) (3) (4) . HTLV-I, HTLV type II (HTLV-II), and bovine leukemia virus share common structural and biological features that distinguish them from the other nonacute retroviruses. These include: unusually large long terminal repeat (LTR) sequences (5-7), the presence of an x-lor or tat gene between the env gene and the 3' LTR (8) (9) (10) (11) , and the ability of viral-associated trans-acting transcription factors to increase the rate of LTR-directed gene expression (12) (13) (14) (15) . In addition, both HTLV-I and HTLV-II are able to immortalize primary lymphocytes in vitro (16, 17) . Recent studies have shown that the HTLV-I and HTLV-II tat genes encode 42-and 38-kDa nuclear proteins, respectively (18) (19) (20) and that the tat products, in the absence of other viral proteins, activate in trans gene expression directed by the HTLV-I and -II LTRs (21) .
In the present study we used a transient gene expression assay to identify the functional domains within the HTLV-I LTR. The results demonstrate that the LTR contains functional enhancer and promoter sequences. The enhancer activity is evident in cells of lymphoid and nonlymphoid origin. Furthermore, neither the enhancer nor the promoter sequences contain in their entirety those sequences responsive to the viral trans-acting factors. Plasmid Constructions. Plasmid pU3R-I (12) contains the HTLV-I LTR sequences upstream of the bacterial chloramphenicol acetyltransferase gene (CAT) (24) . Deletion mutants ofthe LTR were constructed as follows. Plasmid pU3R-1 was first cleaved at the unique Sma I site at nucleotide -332 within the LTR, and deletion mutants were generated with the exonuclease BAL-31 (25) . Synthetic Xho I linkers were ligated to the DNA, and Maxam and Gilbert DNA sequence analysis (26) was used to determine the end point of each deletion. The name of each plasmid is indicative of the number of nucleotides present relative to the transcription start site (5) . Construction of the additional plasmids used to assess promoter and enhancer activity was performed by using standard recombinant DNA methodology (27) . LTR regions used for each construction are described in the text and figure legends.
MATERIALS AND METHODS
Eukaryotic Cell Transfections and CAT Assays. The HeLa and CCCS'L-cells were transfected with 2 jig of plasmid DNA by a modification of the calcium phosphate coprecipitation technique (28) . Lymphoid cells were transfected by the DEAE-dextran method as described by Queen and Baltimore (29) . CAT assays were performed as described (12, 24) .
RESULTS'
Deletion Analysis. To identify cis-acting regulatory sequences 5' to the "TATA" sequence, a series of 5' deletion mutants were constructed in plasmid pU3R-I (Fig. 1) which the entire 21-bp repeat has been deleted was almost completely abolished. Evidently, neither the two remaining 21-bp repeats nor the 51-bp imperfect direct repeat is sufficient to direct high levels of gene expression in uninfected cells.
We note that the extent of diminution of the activity experienced with each deletion differs depending upon the cell line used. This finding suggests that transcription factors unique to each cell type may interact with different LTR sequences.
HTLV-I Enhancer Activity. The LTR sequences of many retroviruses have been shown to harbor enhancer elements (31, (37) (38) (39) (40) . Since the deletion analysis demonstrated a loss in promotional activity following removal of LTR U3 sequences, we sought to determine whether sequences within this region might serve as enhancer elements.
For this purpose, the portion of the LTR extending from the 5' terminus to a position 35 nucleotides 5' to the TATA sequence was inserted in both the sense and antisense orientation 5' to the simian virus 40 (SV40) early region promoter (Fig. 2 Left). Transfection with plasmid pSV1XCAT (37) that contains the SV40 early region promoter minus the 72-bp SV40 enhancer demonstrated little CAT activity in HeLa and feline epithelial CCCS'L-cells (Fig.   3A) .
However, the level of CAT activity increased significantly after addition of the HTLV U3 sequences in either the sense (pHElCAT) or antisense (pHE2CAT) orientation. To determine if the activity of the distal HTLV-I sequences was dependent upon the SV40 promoter, we deleted the SV40 promoter sequence. The remaining sequences present on these plasmids (pHE2CAT-D and pHLTR-D) did not direct a detectable level of CAT enzyme activity. Hence, the increase in CAT activity after addition of the HTLV-I U3 sequences is dependent upon the SV40 promoter. To examine whether promoter function could be stimulated over a longer distance, plasmids pHLTRS and pHLTRA that contain the entire HTLV-LTR U3 region 2.8 kilobases away from the HTLV-I promoter region (nucleotides -55 to + 315) were tested. Transfection of HeLa, CCCS+L-, and Raji cells with these plasmids gave significantly higher levels of CAT activity as compared with that directed by plasmid pC55 alone (Fig. 3b) .
From these experiments we conclude that U3 region sequences located between nucleotides -350 and -55 function as enhancer elements.
HTLV-I Promoter Sequences. The promoters of most viral LTRs are located near the site of initiation and often include the sequence TATA. To determine whether nucleotides near the TATA site could serve as an initiation sequence for a heterologous enhancer, the HTLV-I LTR sequence extending from -55 to +315 was tested for its ability to respond to enhancers. For this purpose sequences excised from the RSV LTR (31) that possess enhancer activity were placed 5' to the deleted HTLV-I LTR (Fig. 2 Left) . The HTLV enhancer sequences (located between positions -350 and -55) were also placed in reverse orientation 5' to the test HTLV-I sequence. Hybrid plasmids containing the SV40 early promoter region and the U3 enhancer regions of HTLV and RSV were also constructed to permit comparison of promoter function (Fig. 2 Left) .
Addition of either the RSV or HTLV-I enhancer elements 5' to the HTLV-I promoter sequence significantly increased the level of CAT gene expression in human T and B lymphocytes and CCCS'L-cells (Table 2 and Fig. 3 ). Similar levels of CAT activity were observed upon transfection of cells with plasmid (pHElCAT) that contains the SV40 promoter element rather than the corresponding HTLV-I sequence. To determine whether RNA initiated from within the HTLV-I sequence in these hybrid recombinant plasmids, plasmids identical to pREH1 and pU3R-I were constructed, except that the CAT coding region was replaced by the cDNA of rabbit f-globin (pREHI-,8 and pU3R-I-,3) (43) . S1 nuclease analysis (44) shows that the length of the protected fragments was similar for the transcripts derived from the intact and hybrid LTRs (Fig. 4) .
From these experiments, we conclude that the HTLV-I nucleotides near the TATA sequence serve a promoter function equivalent to the SV40 promoter sequence in this assay.
The Region Responsive to Viral trans-Acting Factors. The U3-R region of the HTLV-I LTR is responsive to trans- acting factors present in HTLV-I-and HTLV-II-infected cells (12) .
To determine if the respQnsive sequences were located within the enhancer sequence (-350 to -55), the level of CAT activity directed by plasmids pHE2CAT and pHX1CAT was examined in infected and in uninfected cells ( Table 2) . The level of CAT activity directed by these plasmids was found to be the same in both cell types. Thus, sequences responsive to the trans-acting factors are not present in their entirety within the region that contains the HTLV-I enhancer.
The response of the HTLV-I promoter sequence to viral trans-acting factors was also determined. For this purpose the level of CAT activity directed by plasmid pC55 and the hybrid enhancer/promoter plasmids was examined. Fig. 5 and Table 2 (21) . The results of these experiments are shown in Table 1 Deletions extending to within 159 nucleotides of the initiation site do not affect the ability of the LTR sequences to respond to trans-acting factors, although the upstream sequences do contribute to the overall activity of the LTR even in the presence of these factors. In addition, as demonstrated in the infected cells (Table 2) , neither the HTLV-I enhancer nor the HTLV-I promoter sequence contains in their entirety those sequences responsive to the tat protein (Fig. 5) . The shortest fragment that was found to respond to the transacting factors in these experiments extends from position -159 to +315.
DISCUSSION
In the present study, the location of the cis-acting regulatory sequences within the HTLV-I LTR was determined. The sequences from -350 to -55 conform to the formal definition of enhancer elements as they increase the rate of gene expression directed by a heterologous promoter from a distance in an orientation-independent fashion. We note that the HTLV-I enhancer does not contain core enhancer con-
sensus sequences that are present in several other viral and cellular enhancer elements (46) . Since the level of enhancer activity is similar in uninfected and HTLV-infected cells, we conclude that the HTLV-I enhancer element is not responsive to the viral-associated trans-acting regulatory factors. In this respect, the enhancer element of HTLV-I differs from those of HTLV-II and bovine leukemia virus that are active only in cells that contain the viral-associated trans-acting regulatory factors (our unpublished results).
The function of the HTLV-I enhancer is not restricted to cells of lymphoid origin as enhancer activity is evident in feline epithelial cells and HeLa cells. These observations suggest that the T-cell tropism associated with HTLV-I infection in vivo is not determined by the enhancer element alone. In this respect, the HTLV-I enhancer differs from the T-cell tropic murine leukemia virus enhancers (37, 42, 47 (21) . Cells were transfected with 0.5 ,g of the indicated plasmid together with 3 &g of plasmid pCATLORI (expressor) or pCATLOR11fs (frame-shift mutation). CAT assays were performed 48 hr after transfection. Proc. Natl. Acad. Sci. USA 82 (1985) enhancer or promoter sequence. We propose that the sequence responsive to the viral trans-acting factors be termed the TAR element, for trans-acting response (or target) sequence. The location of the TAR sequence, proximal to the promoter and separate from the enhancer, suggests that trans-acting factors serve to increase the efficiency of transcriptional initiation. This speculation is in accord with the observation that the level of mRNA directed by the HTLV-I LTR is greatly increased in infected cells as compared to uninfected cells (12) . In this regard, the tat gene should play an important role in the life cycle of the virus, inducing an autostimulatory replication cycle, whereby a product of HTLV-I transcription positively activates the HTLV-I LTR. We have proposed that the specificity for transformation of HTLV I and II for T lymphocytes is conferred by the specificity of the tat protein (12, 21) . Although the tat protein can stimulate HTLV LTR-directed transcription in many cells, we speculate that the ability to regulate cellular genes that control cellular proliferation may be limited to lymphoid cells, or alternatively, that genes regulated by the tat protein only induce proliferation in lymphoid cells.
Further studies regarding mechanisms that regulate control of viral gene expression may provide insight into those mechanisms by which viral proteins regulate cellular genes.
